Literature DB >> 15355426

Will the new cytogenetics replace the old cytogenetics?

M Salman1, S C Jhanwar, H Ostrer.   

Abstract

With the advent of array-based comparative genomic hybridization technology, the analog cytogenetic analysis that has been used for the past 100 years could be replaced by the quantitative, microarray-based molecular analysis. Major advantages of the new array-based cytogenetic technologies are the high resolution and the high throughput. This technology is the first to offer an autonomous whole-chromosome analysis in one hybridization reaction for the detection of submicroscopic gains/losses. However, as with any new technology, it needs to be validated with regard to its performance in various applications (e.g. clinical genetic testing and cancer applications), comparative cost, and the data interpretation.

Entities:  

Mesh:

Year:  2004        PMID: 15355426     DOI: 10.1111/j.1399-0004.2004.00316.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  9 in total

1.  Systematic screening for subtelomeric anomalies in a clinical sample of autism.

Authors:  Thomas H Wassink; Molly Losh; Joseph Piven; Val C Sheffield; Elizabeth Ashley; Erik R Westin; Shivanand R Patil
Journal:  J Autism Dev Disord       Date:  2007-04

Review 2.  Chromosome analysis: what and when to request.

Authors:  F H Sharkey; E Maher; D R FitzPatrick
Journal:  Arch Dis Child       Date:  2005-12       Impact factor: 3.791

3.  Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies.

Authors:  Fabio Parisi; Stephan Ariyan; Deepak Narayan; Antonella Bacchiocchi; Kathleen Hoyt; Elaine Cheng; Fang Xu; Peining Li; Ruth Halaban; Yuval Kluger
Journal:  BMC Genomics       Date:  2011-05-11       Impact factor: 3.969

4.  Analysis and visualization of chromosomal abnormalities in SNP data with SNPscan.

Authors:  Jason C Ting; Ying Ye; George H Thomas; Ingo Ruczinski; Jonathan Pevsner
Journal:  BMC Bioinformatics       Date:  2006-01-18       Impact factor: 3.169

5.  Distal 10q trisomy with copy number gain in chromosome region 10q23.1-10q25.1: the Wnt signaling pathway is the most pertinent to the gene content in the region of copy number gain: a case report.

Authors:  Siew-Lee Wong; Hsin-Hsu Chou; Chung-Nun Chao; Joseph Hang Leung; Yu-Hsin Chen; Cheng-Da Hsu
Journal:  BMC Res Notes       Date:  2015-06-19

Review 6.  Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential.

Authors:  Claudia Cava; Gloria Bertoli; Isabella Castiglioni
Journal:  BMC Syst Biol       Date:  2015-09-21

7.  Cytogenomic assessment of the diagnosis of 93 patients with developmental delay and multiple congenital abnormalities: The Brazilian experience.

Authors:  Évelin Aline Zanardo; Roberta Lelis Dutra; Flavia Balbo Piazzon; Alexandre Torchio Dias; Gil Monteiro Novo-Filho; Amom Mendes Nascimento; Marília Moreira Montenegro; Jullian Gabriel Damasceno; Fabrícia Andreia Rosa Madia; Thaís Virgínia Moura Machado da Costa; Maria Isabel Melaragno; Chong Ae Kim; Leslie Domenici Kulikowski
Journal:  Clinics (Sao Paulo)       Date:  2017-10       Impact factor: 2.365

8.  Array-based comparative genomic hybridization is more informative than conventional karyotyping and fluorescence in situ hybridization in the analysis of first-trimester spontaneous abortion.

Authors:  Jinsong Gao; Congcong Liu; Fengxia Yao; Na Hao; Jing Zhou; Qian Zhou; Liang Zhang; Xinyan Liu; Xuming Bian; Juntao Liu
Journal:  Mol Cytogenet       Date:  2012-07-16       Impact factor: 2.009

9.  Abnormalities in spontaneous abortions detected by G-banding and chromosomal microarray analysis (CMA) at a national reference laboratory.

Authors:  Boris T Wang; Thomas P Chong; Fatih Z Boyar; Kimberly A Kopita; Leslie P Ross; Mohamed M El-Naggar; Trilochan Sahoo; Jia-Chi Wang; Morteza Hemmat; Mary H Haddadin; Renius Owen; Arturo L Anguiano
Journal:  Mol Cytogenet       Date:  2014-05-22       Impact factor: 2.009

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.